Video

Aasma Shaukat, MD, MPH: Better Detection on Colonoscopies

Author(s):

The age of screening for colon cancer has decreased in recent years.

Detecting polyps on colonoscopies is crucial, particularly as we are decreasing the age of recommended screenings in recent years.

And while colonoscopies have value on their own, utilizing new technology could be beneficial in enhancing the accuracy.

In a late-breaking abstract presented during 2022 Digestive Disease Week Annual Meeting in San Diego, a team of investigators used a real-time computer-aided polyp detection device called SKOUT in an effort to detect additional polyps in colonoscopies.

In an interview with HCPLive®, Aasma Shaukat, MD, MPH, Robert M. and Mary H. Glickman Professor of Medicine and Gastroenterology, Department of Medicine at NYU Grossman School of Medicine , reviewed the results using SKOUT at 5 academic and community centers across the US.

In the 1423 patient study, 682 of which were subject to SKOUT, the investigators found the software system was non-inferior to standard colonoscopy in a decrease of THR (SKOUT = 67.4%, standard = 71.6%, P <.001, NI margin=14%).

The results were similar for both the screening and surveillance arm.

Possibly most importantly, an increase in polyp detection per colonoscopy was seen in the proximal colon (SKOUT = .99, Standard = .84; P <.001) and among polyps 5-9mm in size (SKOUT = 0.68, Standard = 0.53).

Related Videos
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
Davide Matino, MD, MSc: Bringing Marstacimab Treatment to Hemophilia A and B
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
© 2024 MJH Life Sciences

All rights reserved.